Linked research, clinical, and regulatory source pathways.
Company profile
About AMBOSS
AMBOSS is a digital medical knowledge platform created by medical professionals for medical professionals, serving students, clinicians, and educators worldwide. The company provides a comprehensive suite of tools including an extensive medical library with over 1,400 high-yield articles, question banks with 13,900+ exam questions covering USMLE, COMLEX, and specialty board exams, and AI-powered clinical decision support through its AI Mode feature. For medical students, AMBOSS offers integrated study tools, exam preparation resources, and mobile apps that work offline. The platform has demonstrated measurable impact, with AMBOSS users scoring 10.4 points higher on USMLE Step 2 CK compared to non-users. For clinicians, AMBOSS provides evidence-based clinical reference tools, differential diagnosis support, management checklists, clinical calculators, and a comprehensive drug database. The platform's AI Mode, which ranked #1 in the Stanford-Harvard NOHARM Study for clinical care safety, delivers practice-focused AI search capabilities that connect natural-language clinical questions to curated, evidence-based sources. AMBOSS also serves medical schools, PA programs, NP programs, and residency programs with educator tools for creating assignments, monitoring student progress, and providing targeted remediation. The platform integrates with popular tools like Anki, Chrome, and offers both web and mobile access with offline functionality.
Company description AMBOSS official website
Primary marketMedical Education & Training
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at AMBOSS?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
No clinical focus areas are currently listed.
Who it serves
- Advanced Practice Providers
- Attending Physicians
- Medical Educators
- Medical Schools
- Medical Students
- NP Programs
- NP Students
- PA Programs
- PA Students
- Residency Programs
- Residents
Deployment & integration
Deployment information is currently being developed.
Recorded integration context: Anki, ChatGPT, Chrome Extension.
Geographic context
MarketsGermany · International · Poland · Portugal · United States
Company sourceOfficial website
Company milestones
Platform expansion
AI Mode (LiSA 1.0) ranked #1 in Stanford-Harvard NOHARM Study for clinical care safety. Launch of AI Mode for clinical care and AI Mode Learning for students.
Partnerships
Recorded partners
- NEJM Group (courses partnership)
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
No source-backed Company products are currently listed.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Exploring Students' Use of Medical Education Resources for the USMLE Step 2 CK Exam Preparation.Medical science educator · Jun 1, 2025
The Mexican drug war: Homicides and deaths of despair, 2000-2020.Public health · Mar 1, 2025
Medical education videos - comparative analysis of sonography vs. clinical examination videos: user perception and educational value.BMC medical education · Dec 18, 2024
Workforce estimate to treat mental disorders in the Kingdom of Saudi Arabia.Human resources for health · Jul 16, 2024
[Evaluation of the GeSRU-Steps educational video concept (German Society of Residents in Urology e. V.)].Urologie (Heidelberg, Germany) · Apr 1, 2024
Evaluating the Effectiveness of Interactive Virtual Patients for Medical Education in Zambia: Randomized Controlled Trial.JMIR medical education · Jun 29, 2023
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
10.4 points higher USMLE Step 2 CK scores
AMBOSS users vs non-users
95% of residents report improved clinical performance
Residents survey
99.8% user satisfaction
Overall platform users
#1 ranking for clinical care safety
Stanford-Harvard NOHARM Study among 31 AI systems
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from AMBOSS
Recent articles published on AMBOSS's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Medical Education & Training
Companies using AI, virtual reality, augmented reality, or immersive technologies to provide medical education, surgical training, clinical skills development, or continuing medical education for healthcare professionals. Focuses on training and skills development rather than direct patient care delivery.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.